July 24, 2014 5:07 PM ET

Healthcare Providers and Services

Company Overview of 21st Century Oncology Holdings, Inc.

Company Overview

21st Century Oncology Holdings, Inc., together with its subsidiaries, operates as a physician-led provider of integrated cancer care services. Its radiation treatment services include external beam therapies, such as conformal radiation therapy, intensity modulated radiation therapy, and stereotactic radiosurgery, as well as internal radiation therapies, such as high-dose and low-dose rate brachytherapies. The company’s radiation treatment services also comprise image guided radiation therapy, Gamma function testing, and respiratory gating. In addition, it offers support services in the areas of psychological and nutritional counseling, as well as transportation assistance. Further, the comp...

2270 Colonial Boulevard

Fort Myers, FL 33907

United States

Founded in 1983

3,880 Employees

Phone:

239-931-7275

Key Executives for 21st Century Oncology Holdings, Inc.

Co-Founder
Age: 61
Vice Chairman
Age: 53
Chief Executive Officer of Medical Developers Cooperatief U A B V
Age: 55
Executive Vice President and General Counsel
Age: 62
Chief Accounting Officer
Age: 45
Compensation as of Fiscal Year 2014.

21st Century Oncology Holdings, Inc. Key Developments

21st Century Oncology Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

21st Century Oncology Holdings, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenues of $233,397,000 compared to $173,977,000 a year ago. Loss before income taxes was $27,139,000 compared to $17,598,000 a year ago. Net loss was $29,245,000 compared to $19,377,000 a year ago. Net loss attributable to the company’s shareholders of $30,181,000 compared to $19,741,000 a year ago. Net cash used in operating activities of $305,000 compared to net cash provided by operating activities of $8,093,000 a year ago. Purchase of property and equipment was $19,063,000 compared to $9,874,000 a year ago. Pro-forma adjusted EBITDA was $30,455,000 compared to $21,726,000 a year ago. Total pro forma revenues were $242.2 million, compared to $174.0 million in revenues in the same quarter of 2013. The increase in revenue was principally due to increased census, accretive joint ventures and acquisitions and international revenue growth.

21st Century Oncology Holdings, Inc. to Report Q1, 2014 Results on May 29, 2014

21st Century Oncology Holdings, Inc. announced that they will report Q1, 2014 results at 9:00 AM, Eastern Standard Time on May 29, 2014

21st Century Oncology Holdings, Inc., Q1 2014 Earnings Call, May 29, 2014

21st Century Oncology Holdings, Inc., Q1 2014 Earnings Call, May 29, 2014

Similar Private Companies By Industry

Company Name Region
Holzer Medical Center - Jackson United States
Brentwood Hospital Inc. United States
Kettering Medical Center Inc United States
Tenet HealthSystem St. Christopher's Hospital For Children, L.L.C. United States
Children's Cardiology Associates, PLLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 15, 2014
Roger Williams Radiation Therapy, Llc
Merger/Acquisition
May 15, 2014
Southern New England Regional Cancer Center, LLC
Merger/Acquisition
May 1, 2014
Radiation Oncology Facility in Guatemala
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 21st Century Oncology Holdings, Inc., please visit www.rtsx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.